M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials
Revolutionary limb saving procedure set to benefit patients with Chronic Limb-Threatening Ischemia, typically caused by Type 2 Diabetes SINGAPORE - Media OutReach - 15 September 2023 - M&L Healthcare , in its first major MedTech investment, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of the LimFlow System - a revolutionary therapy providing l...
read full article
